Black, M.D., Stevens, R.J., Rogacki, N., et al. (2010) AVE1625, a Cannabinoid CB1 Receptor Antagonist, as a Co-Treatment with Antipsychotics for Schizophrenia: Improvement in Cognitive Function and Reduction of Antipsychotic-Side Effects in Rodents. Psychopharmacology, 215, 149-163.

精神分裂症治疗相关靶点及药物研究进展
Receptors and Related Drug Development for Schizophrenia: Research Advances

贾晓凤, 何 玲    科研立项经费支持

药物资讯Vol.5 No.2, 全文下载: PDF HTML XML DOI:10.12677/PI.2016.52004, April 29 2016

临床用阿片受体拮抗剂研究进展
Research Progress of Opioid Receptor Antagonist Used in Clinic

王 乔, 舒 浪, 刘 明, 邵开元, 胡文祥   

有机化学研究Vol.3 No.1, 全文下载: PDF HTML XML DOI:10.12677/JOCR.2015.31002, February 10 2015

成年期和青少年期使用抗精神病药对认知功能的不同影响
The Different Effects of Antipsychotic Drugs on Cognitive Function in Adulthood and Adolescence

程 鹏, 高 军    科研立项经费支持

心理学进展Vol.8 No.10, 全文下载: PDF HTML XML DOI:10.12677/AP.2018.810169, October 9 2018

利培酮治疗精神分裂症的临床效果及经济性研究进展
Research Progress on the Clinical Effect and Economy of Risperidone in the Treatment of Schizophrenia

裴瑞琳, 张 雄   

临床医学进展Vol.14 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.142476, February 23 2024

IVF-ET拮抗剂方案黄体支持研究进展
Clinical Research Progress on Luteal Phase Support of Antagonist in IVF-ET

陈琰睿, 师娟子, 李 娜   

临床医学进展Vol.13 No.4, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.134738, April 10 2023

IL-36受体拮抗剂治疗泛发性脓疱型银屑病的机制及研究进展
Mechanism and Progress of Interleukin-36 Receptor Antagonist in the Treatment of Generalized Pustular Psoriasis

杨 晶, 肖异珠   

临床医学进展Vol.12 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.125658, May 27 2022